Gluten makes people sick, through celiac disease, gluten sensitivity or allergy. But, where do you find the medical research that proves it, especially to skeptics? This short video shows you where to go.
Jennifer Iscol, of the Celiac Community Foundation of Northern California, just distributed this message regarding a celiac disease study at Stanford University.
“Volunteers are needed for a genetic study on celiac disease at Stanford University. Please consider participating. Community participation is an essential component of Stanford’s celiac disease research. The research benefits all of us and future generations.
Announcement from Stanford:
We are conducting a study to understand the genetic basis of celiac disease. Families with at least one parent and one child with celiac disease are encouraged to enroll together.
The study involves: Read More »
BioLineRx Ltd, a biopharmaceutical development company, was invited to deliver an oral presentation at the recent 2013 National Education Conference & Gluten-Free Expo, the Celiac Disease Foundation’s annual conference, in Pasadena, California.
Leah Klapper, Ph.D., General Manager, BioLine Innovations Jerusalem, presented BioLineRx’s therapy, BL-7010, for the treatment of celiac, as part of a session entitled Breaking Therapies Beyond the Gluten-Free Diet.
BL-7010 will be presented at Read More »
In this video, Dr. Osborne discusses the benefits of the gluten-free diet as well as the Paleo diet in an interview with FOX News.
[amzn_multi_product_inline keyword=’paleo, gluten-free’ count=’5′ page=” sort=” category=”]
December 7, 2012: Port Charlotte, Florida. Gluten Free Works Inc. announced the launch of its newest online publication, Celiac Disease Today.
In our ongoing efforts to help people get well and stay healthy, living gluten free, Gluten Free Works is proud to distribute the first issue of Celiac Disease Today, a special new monthly e-newsletter for gluten-free support group leaders.
As the name suggests, Celiac Disease Today focuses on the health and wellness aspects of celiac disease, complete with accurate and up-to-date information regarding symptoms, research, diagnosis and Read More »
The Food Allergen Labeling and Consumer Protection Act passed in 2004 and it required the FDA to set gluten-free labeling legislation by 2008, but here we are in October 2012 with no finalized gluten-free labeling legislation. There is now an open petition on the White House website asking the Obama administration to finalize gluten-free labeling now.
Weight loss, fad, miracle cure…there is an enormous amount of misinformation concerning the gluten-free diet in the news, on the internet and even in the medical community.
One of the worst ideas being perpetuated is that following a gluten-free diet can somehow be bad for you.
Dr. Stefano Guandalini, Founder and Medical Director of Columbia University’s Celiac Disease Center, answers the important question – Could following a gluten-free diet lead to other diseases?
Medical Research Study to Test a Potential Celiac Disease Therapy Is Underway and Signing up Participants
There is no cure for celiac disease. But, there may soon be a new therapy to go along with a gluten-free diet.
A Phase II medical research study to test a potential therapy for people with celiac disease is underway and signing up participants at CeliacTrial.com.
The investigational drug, Larazotide Acetate, was developed by Alba Therapeutics. It passed Phase I trials and is now being studied to determine how effective it is in different doses and whether side effects develop. Alba Therapeutics was co-founded by celiac disease researcher, Dr. Alessio Fasano, director of the Celiac Disease Center at the University of Maryland.1
The therapy is based on Dr. Fasano’s discovery that tight junctions between cells in the intestine can be opened or closed and that gluten relaxes these junctions. It is this process that leads to gluten improperly crossing into the body, thereby eliciting an immune reaction that leads to inflammation and damage characteristic of celiac disease.
“The reality is that the paracellular space is a gate, not a wall or fence. And if material gets through that space – even if it is only 1 to 5% of what normally travels through the cell – it could be associated with disease.”
-Alessio Fasano, MD1
Dr. Fasano discovered the potentially therapeutic utility of down-regulating intestinal permeability of celiac disease.1 In other words, he discovered that Read More »
Domino’s Pizza recently announced it would offer gluten-free pizza for gluten sensitive customers. Domino’s made it clear that the pizzas used a gluten-free crust, but are manufactured using the same equipment as the other gluten-containing foods and are not safe for people with celiac disease.
Domino’s worked with the National Foundation for Celiac Awareness (NFCA) and received the NFCA’s new, and now suspended, “Amber Designation.” This designation was to tell people that although the ingredients are gluten-free, the product cannot claim that cross contamination does not occur. The “Amber Designation” differed from the NFCA’s existing “Green Designation,” which tells the customer that the product is tested to less than 10 parts per million of gluten. “Amber” was basically a caution sign.
What Did Gluten-Free Watchdog Organizations Say?
- The Gluten Intolerance Group (GIG) and other organizations called for a recall of the NFCA’s “Amber Designation.”
- The North American Society for the Study of Celiac Disease commented on Domino’s Pizza ‘Gluten-Free’ Crust Announcement as follows,